Yahoo Finance1d
MDT Stock Gains From FDA Approval for Its InPen App
This latest FDA clearance should pave the way for the launch of the company’s Smart MDI system, which combines the InPen ...
While legalizing marijuana is in limbo, FDA clears a PTSD study that could boost cannabis stocks over time
The move marks a rare action by the FDA to sanction a study on cannabis despite the plant’s current Schedule I classification ...
WebMD4d
First-in-Class Leukemia Treatment Approved by FDA
The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.
Jazz Pharmaceuticals receives FDA approval for biliary tract cancer treatment
The U.S. Food and Drug Administration approved Jazz Pharmaceuticals' drug, zanidatamab-hrii, for the treatment of a type of ...
Benzinga.com1d
Y-mAbs' Omburtamab Failure: The Critical Turning Point And $19.65M Shareholder Settlement
The results pave the way for our multicenter phase 2 study in DIPG ... investors sued Y-mAbs for misleading about the FDA approval. Resolving The Case To resolve the lawsuit from investors, Y-mAbs has ...
In RFK Jr., drugmakers face an antagonist with regulatory power
Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...
BioSpace4d
BridgeBio Wins FDA Approval for ATTR-CM Drug, Launching Competition with Pfizer
Experts view BridgeBio’s acoramidis—which has an FDA action date of Nov. 29—as either similar to or incrementally better than ...